Accordingly, the results of the present study demonstrated that patients with severe COVID-19 had higher levels of several inflammatory biomarkers (e.g., NLR, CRP, procalcitonin, PCT, IL-6, and IL-10 levels). The gene discussed is IL10; the disease is COVID-19.